Currently, mutations in four different proteins (BRAF, GNAQ/GNA11, cKIT, NRAS) are well known to occur during melanoma formation, and affect the MAPK pathways by disrupting the healthy cells’ response to the emerging oncogenes. The gene discussed is NRAS; the disease is melanoma.